Literature DB >> 12682118

Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR.

Oliver Greiner1, Philip J R Day, Martin Altwegg, David Nadal.   

Abstract

The recognition of Moraxella catarrhalis as an important cause of respiratory tract infections has been protracted, mainly because it is a frequent commensal organism of the upper respiratory tract and the diagnostic sensitivity of blood or pleural fluid culture is low. Given that the amount of M. catarrhalis bacteria in the upper respiratory tract may change during infection, quantification of these bacteria in nasopharyngeal secretions (NPSs) by real-time PCR may offer a suitable diagnostic approach. Using primers and a fluorescent probe specific for the copB outer membrane protein gene, we detected DNA from serial dilutions of M. catarrhalis cells corresponding to 1 to 10(6) cells. Importantly, there was no difference in the amplification efficiency when the same DNA was mixed with DNA from NPSs devoid of M. catarrhalis. The specificity of the reaction was further confirmed by the lack of amplification of DNAs from other Moraxella species, nontypeable Haemophilus influenzae, H. influenzae type b, Streptococcus pneumoniae, Streptococcus oralis, Streptococcus pyogenes, Bordetella pertussis, Corynebacterium diphtheriae, and various Neisseria species. The assay applied to NPSs from 184 patients with respiratory tract infections performed with a sensitivity of 100% and a specificity of up to 98% compared to the culture results. The numbers of M. catarrhalis organisms detected by real-time PCR correlated with the numbers detected by semiquantitative culture. This real-time PCR assay targeting the copB outer membrane protein gene provided a sensitive and reliable means for the rapid detection and quantification of M. catarrhalis in NPSs; may serve as a tool to study changes in the amounts of M. catarrhalis during lower respiratory tract infections or following vaccination against S. pneumoniae, H. influenzae, or N. meningitidis; and may be applied to other clinical samples.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12682118      PMCID: PMC153888          DOI: 10.1128/JCM.41.4.1386-1390.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  31 in total

1.  Clinically applicable multiplex PCR for four middle ear pathogens.

Authors:  P H Hendolin; L Paulin; J Ylikoski
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Genetic diversity among strains of Moraxella catarrhalis cultured from the nasopharynx of young and healthy Brazilian, Angolan and Dutch children.

Authors:  B Wolf; M Kools-Sijmons; C Verduin; L C Rey; A Gama; J Roord; J Verhoef; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-10       Impact factor: 3.267

3.  Quantitative real-time PCR for Porphyromonas gingivalis and total bacteria.

Authors:  S R Lyons; A L Griffen; E J Leys
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

4.  Bacteriological and PCR analysis of clinical material aspirated from otitis media with effusions.

Authors:  U Gok; Y Bulut; E Keles; S Yalcin; M Z Doymaz
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2001-07-30       Impact factor: 1.675

5.  Immune response to surface protein A of Streptococcus pneumoniae and to high-molecular-weight outer membrane protein A of Moraxella catarrhalis in children with acute otitis media.

Authors:  T Samukawa; N Yamanaka; S Hollingshead; T F Murphy; H Faden
Journal:  J Infect Dis       Date:  2000-05-15       Impact factor: 5.226

6.  Antigenic heterogeneity and molecular analysis of CopB of Moraxella (Branhamella) catarrhalis.

Authors:  S Sethi; J M Surface; T F Murphy
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

7.  Rapid detection of Mycoplasma pneumoniae in clinical samples by real-time PCR.

Authors:  D Hardegger; D Nadal; W Bossart; M Altwegg; F Dutly
Journal:  J Microbiol Methods       Date:  2000-06       Impact factor: 2.363

8.  Development and evaluation of a broad-range PCR-ELISA assay with Borrelia burgdorferi and Streptococcus pneumoniae as model organisms for reactive arthritis and bacterial meningitis.

Authors:  C Fischer-Romero; J Lüthy-Hottenstein; M Altwegg
Journal:  J Microbiol Methods       Date:  2000-03       Impact factor: 2.363

Review 9.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

10.  Etiology of community-acquired pneumonia in 254 hospitalized children.

Authors:  T Juvén; J Mertsola; M Waris; M Leinonen; O Meurman; M Roivainen; J Eskola; P Saikku; O Ruuskanen
Journal:  Pediatr Infect Dis J       Date:  2000-04       Impact factor: 2.129

View more
  23 in total

Review 1.  Real-time PCR in clinical microbiology: applications for routine laboratory testing.

Authors:  M J Espy; J R Uhl; L M Sloan; S P Buckwalter; M F Jones; E A Vetter; J D C Yao; N L Wengenack; J E Rosenblatt; F R Cockerill; T F Smith
Journal:  Clin Microbiol Rev       Date:  2006-01       Impact factor: 26.132

Review 2.  Antibiotics for acute laryngitis in adults.

Authors:  Ludovic Reveiz; Andrés Felipe Cardona
Journal:  Cochrane Database Syst Rev       Date:  2015-05-23

3.  Viral-bacterial co-infection in Australian Indigenous children with acute otitis media.

Authors:  Michael J Binks; Allen C Cheng; Heidi Smith-Vaughan; Theo Sloots; Michael Nissen; David Whiley; Joseph McDonnell; Amanda J Leach
Journal:  BMC Infect Dis       Date:  2011-06-07       Impact factor: 3.090

4.  Effect of pneumococcal vaccination on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Fijian children.

Authors:  Eileen M Dunne; Jayne Manning; Fiona M Russell; Roy M Robins-Browne; E Kim Mulholland; Catherine Satzke
Journal:  J Clin Microbiol       Date:  2011-12-14       Impact factor: 5.948

5.  Detection of Haemophilus influenzae type b by real-time PCR.

Authors:  Adrian Marty; Oliver Greiner; Philip J R Day; Sibylle Gunziger; Kathrin Mühlemann; David Nadal
Journal:  J Clin Microbiol       Date:  2004-08       Impact factor: 5.948

6.  Detection of pathogenic bacteria during rhinovirus infection is associated with increased respiratory symptoms and asthma exacerbations.

Authors:  Kirsten M Kloepfer; Wai Ming Lee; Tressa E Pappas; Theresa J Kang; Rose F Vrtis; Michael D Evans; Ronald E Gangnon; Yury A Bochkov; Daniel J Jackson; Robert F Lemanske; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2014-04-01       Impact factor: 10.793

7.  Association of targeted multiplex PCR with resequencing microarray for the detection of multiple respiratory pathogens.

Authors:  Hongwei Shen; Bingqing Zhu; Shulian Wang; Haolian Mo; Ji Wang; Jin Li; Chen Zhang; Huashu Zeng; Li Guan; Weixian Shi; Yong Zhang; Xuejun Ma
Journal:  Front Microbiol       Date:  2015-05-28       Impact factor: 5.640

8.  Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections.

Authors:  N J Gadsby; M P McHugh; C D Russell; H Mark; A Conway Morris; I F Laurenson; A T Hill; K E Templeton
Journal:  Clin Microbiol Infect       Date:  2015-05-14       Impact factor: 8.067

9.  Quantitative analysis of pathogens in the lower respiratory tract of patients with chronic obstructive pulmonary disease.

Authors:  Huaying Wang; Xiao Gu; Yuesong Weng; Tao Xu; Zhongming Fu; Weidong Peng; Wanjun Yu
Journal:  BMC Pulm Med       Date:  2015-08-19       Impact factor: 3.317

10.  What is behind the ear drum? The microbiology of otitis media and the nasopharyngeal flora in children in the era of pneumococcal vaccination.

Authors:  Nikki Mills; Emma J Best; David Murdoch; Melanie Souter; Michel Neeff; Trevor Anderson; Lesley Salkeld; Zahoor Ahmad; Murali Mahadevan; Colin Barber; Colin Brown; Cameron Walker; Tony Walls
Journal:  J Paediatr Child Health       Date:  2014-09-01       Impact factor: 1.954

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.